Izotropic Corporation
IZO
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 273.18% | -93.04% | 238.63% | -89.18% | -95.59% |
| Depreciation & Amortization | -12.96% | -10.81% | -15.60% | 2.83% | 40.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.34% | -66.29% | 171.18% | -72.58% | -88.13% |
| Operating Income | -54.34% | 66.29% | -171.18% | 72.58% | 88.13% |
| Income Before Tax | -55.58% | 56.67% | -159.89% | 100.01% | 85.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.58% | 56.67% | -159.89% | 100.01% | 85.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.58% | 56.67% | -159.89% | 100.01% | 85.11% |
| EBIT | -54.34% | 66.29% | -171.18% | 72.58% | 88.13% |
| EBITDA | -63.72% | 66.09% | -180.15% | 72.96% | 88.85% |
| EPS Basic | -41.46% | 59.09% | -141.18% | 100.00% | 85.71% |
| Normalized Basic EPS | -44.00% | 59.42% | -139.53% | 67.86% | 86.03% |
| EPS Diluted | -41.46% | 59.09% | -141.18% | 100.00% | 85.71% |
| Normalized Diluted EPS | -44.00% | 59.42% | -139.53% | 67.86% | 86.03% |
| Average Basic Shares Outstanding | 8.54% | 6.71% | 7.87% | 7.38% | 5.40% |
| Average Diluted Shares Outstanding | 8.54% | 6.71% | 7.87% | 7.38% | 5.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |